Cited by 1,228Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment ApproachesInfective Endocarditis Diagnosis and Management

Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients

Open access
Gilard, Martine, Eltchaninoff, Hélène, Iung, Bernard, Donzeau-Gouge, Patrick, Chevreul, Karine, Fajadet, Jean, Leprince, Pascal, Leguerrier, Alain +34 more·2012·New England Journal of Medicine

Abstract

BACKGROUND: Transcatheter aortic-valve implantation (TAVI) is an emerging intervention for the treatment of high-risk patients with severe aortic stenosis and coexisting illnesses. We report the results of a prospective multicenter study of the French national transcatheter aortic-valve implantation registry, FRANCE 2. METHODS: All TAVIs performed in France, as listed in the FRANCE 2 registry, were prospectively included in the study. The primary end point was death from any cause. RESULTS: A total of 3195 patients were enrolled between January 2010 and October 2011 at 34 centers. The mean (±SD) age was 82.7±7.2 years; 49% of the patients were women. All patients were highly symptomatic and were at high surgical risk for aortic-valve replacement. Edwards SAPIEN and Medtronic CoreValve devices were implanted in 66.9% and 33.1% of patients, respectively. Approaches were either transarterial (transfemoral, 74.6%; subclavian, 5.8%; and other, 1.8%) or transapical (17.8%). The procedural success rate was 96.9%. Rates of death at 30 days and 1 year were 9.7% and 24.0%, respectively. At 1 year, the incidence of stroke was 4.1%, and the incidence of periprosthetic aortic regurgitation was 64.5%. In a multivariate model, a higher logistic risk score on the European System for Cardiac Operative Risk Evaluation (EuroSCORE), New York Heart Association functional class III or IV symptoms, the use of a transapical TAVI approach, and a higher amount of periprosthetic regurgitation were significantly associated with reduced survival. CONCLUSIONS: This prospective registry study reflected real-life TAVI experience in high-risk elderly patients with aortic stenosis, in whom TAVI appeared to be a reasonable option. (Funded by Edwards Lifesciences and Medtronic.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1114705

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Balloon-expandable and self-expanding transcatheter valves, specifically CoreValve and SAPIEN, have been the most rigorously studied to date.

    “Balloon-expandable and self-expanding transcatheter valves have been the most rigorously studied to date, specifically the CoreValve (Medtronic, Dublin, Ireland) and SAPIEN (Edwards, Irvine CA, USA) valves”

    From Calcific aortic stenosis (2016) · cites this paper as [226]

    The Patients and Study Devices and Procedures sections identify SAPIEN as balloon-expandable and CoreValve as self-expanding; the Results section reports their use in 3,195 registry patients. The paper does not establish that these were the most rigorously studied transcatheter valves relative to other devices. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Approximately two-thirds, or 56-75%, of TAVR procedures are performed using a transfemoral approach.

    “Approximately two-thirds (56–75%) of TAVR procedures are performed via a transfemoral approach226–229.”

    From Calcific aortic stenosis (2016) · cites this paper as [226]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [13]13. Kahlert P, Erbel R. Transcatheter aor- tic valve implantation in the era after com- mercialization: quo vadis in the real world? Circulation 2011;123:239-41.

Cited by

Sorted by citations

Authors
Gilard, M., Eltchaninoff, H., Iung, B., Donzeau-Gouge, P., Chevreul, K., Fajadet, J., Leprince, P., Leguerrier, A., Lievre, M., Prat, A., Teiger, E., Lefevre, T., Himbert, D., Tchetche, D., Carrié, D., Albat, B., Cribier, A., Rioufol, G., Sudre, A., Blanchard, D., Collet, F., Santos, P. D., Meneveau, N., Tirouvanziam, A., Caussin, C., Guyon, P., Boschat, J., Le Breton, H., Collart, F., Houel, R., Delpine, S., Souteyrand, G., Favereau, X., Ohlmann, P., Doisy, V., Grollier, G., Gommeaux, A., Claudel, J.-P., Bourlon, F., Bertrand, B., Van Belle, E., & Laskar, M.
Affiliations
  • Centre Hospitalier Régional Universitaire de Brest (FR)
  • Inserm (FR)
  • Hôpital Bichat-Claude-Bernard (FR)
  • Centre Hospitalier Universitaire Henri-Mondor (FR)
  • Clinique Pasteur (FR)
  • Pitié-Salpêtrière Hospital (FR)
  • Centre Hospitalier Universitaire de Rennes (FR)
  • Centre Hospitalier Universitaire de Lille (FR)
  • Centre Hospitalier Universitaire de Toulouse (FR)
  • Centre Hospitalier Universitaire de Montpellier (FR)
  • Hôpital privé Clairval (FR)
  • Centre Hospitalier Universitaire de Besançon (FR)
  • Centre Hospitalier Universitaire de Nantes (FR)
  • Hôpital Marie Lannelongue (FR)
  • Centre Cardiologique du Nord (FR)
  • Centre Hospitalier Universitaire d'Angers (FR)
  • Hôpitaux Universitaires de Strasbourg (FR)
  • Centre Hospitalier Universitaire de Caen Normandie (FR)
  • Infirmerie Protestante (FR)
  • Centre Hospitalier Saint-Charles (FR)
  • Centre Hospitalier Universitaire de Grenoble (FR)
  • Hôpital Universitaire Dupuytren (FR)
Venue
New England Journal of Medicine
Published
2012-05-03
Volume
366
Issue
18
Pages
1705-1715
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2108007523
Cited by
1,228
References
29
Citations by year
2026: 14 · 2025: 21 · 2024: 22 · 2023: 18 · 2022: 35 · 2021: 36 · 2020: 60 · 2019: 68 · 2018: 103 · 2017: 115 · 2016: 150 · 2015: 174 · 2014: 153 · 2013: 196 · 2012: 54
FWCI
117.77
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
Edwards Lifesciences
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Aortic Disease and Treatment Approaches
  • Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
Keywords
transcatheter aortic valve implantation, severe aortic stenosis, high surgical risk, elderly patients, mortality, stroke, transapical approach, transfemoral access, EuroSCORE, survival predictors, Edwards SAPIEN, Medtronic CoreValve
MeSH terms
Aged, Aged, 80 and over, Aortic Valve Stenosis, Female, France, Cardiac Catheterization, Heart Valve Prosthesis, Hemorrhage, Humans, Male, Prospective Studies, Registries, Incidence, Multivariate Analysis, Heart Valve Prosthesis Implantation, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review